Prakriti Roy
Overview
Explore the profile of Prakriti Roy including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
50
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Roy P, van Peer S, Dandis R, Duncan C, de Aguirre-Neto J, Verschuur A, et al.
Cancer Med
. 2023 Jul;
12(16):17098-17111.
PMID: 37496317
Background: The COVID-19 pandemic had global catastrophic effects on the management of non-communicable diseases including paediatric cancers. Restrictions during the start of 2020 complicated timely referrals of patients to specialized...
2.
Schulpen M, Roy P, Wijnen M, Tytgat G, van den Heuvel-Eibrink M, van Tinteren H, et al.
Eur J Cancer
. 2022 Sep;
175:282-290.
PMID: 36174300
Background: This population-based study is the first to provide a detailed analysis of trends in incidence and survival of children and adolescents diagnosed with renal malignancies in the Netherlands. Methods:...
3.
Das N, Banavali S, Bakhshi S, Trehan A, Radhakrishnan V, Seth R, et al.
Trials
. 2022 Feb;
23(1):102.
PMID: 35101099
Background: In the west, survival following treatment of childhood acute lymphoblastic leukaemia (ALL) approaches 90%. Outcomes in India do not exceed 70%. To address this disparity, the Indian Collaborative Childhood...
4.
Roy P, van Peer S, de Witte M, Tytgat G, Karim-Kos H, van Grotel M, et al.
PLoS One
. 2022 Jan;
17(1):e0261729.
PMID: 35025887
Around 6% of all childhood malignancies represent renal tumors, of which a majority includes Wilms tumor (WT). Although survival rates have improved over the last decades, specific patients are still...
5.
Sidhu J, Gogoi M, Agarwal P, Mukherjee T, Saha D, Bose P, et al.
Pediatr Blood Cancer
. 2021 May;
68(11):e29046.
PMID: 33939263
Background: The biotherapeutic asparaginase is a cornerstone of therapy in acute lymphoblastic leukaemia (ALL). With limited access to the original native Escherichia coli-derived asparaginase (EcASNase), a variety of EcASNase biogenerics...
6.
Mul J, van Grotel M, Seravalli E, Bosman M, van Tinteren H, Roy P, et al.
Radiother Oncol
. 2021 Apr;
159:249-254.
PMID: 33845042
Background And Purpose: In pediatric renal tumors, conventional two opposing photon beams have been used to cover the postoperative flank target volume for decades. This single center study describes the...
7.
Roy P, Islam R, Saha D, Gogoi M, Mishra D, Arora N, et al.
Br J Haematol
. 2019 Jun;
186(6):861-865.
PMID: 31168836
The feasibility of bortezomib (BZB) in induction and reduced cytarabine doses in intensification was evaluated in children with relapsed acute lymphoblastic leukaemia (rALL) at a single centre in India. Of...